Cardiovascular and metabolic outcome in 6–8 year old offspring of women with type 1 diabetes with near-optimal glycaemic control during pregnancy

详细信息    查看全文

• 作者：Maarten Rijpert ; Inge M. Evers ; Harold W. de Valk ; Monique A.M.J. de Vroede ; Marijke Tersteeg-Kamperman ; Cobi J. Heijnen ; Gerard H.A. Visser
• 关键词：Type 1 diabetes ; Pregnancy ; Follow-up ; Child development ; Cardiovascular disease ; Metabolic Syndrome
• 刊名：Early Human Development
• 出版年：2011
• 出版时间：January 2011
• 年：2011
• 卷：87
• 期：1
• 页码：49-54
• 全文大小：209 K

文摘

Background

High maternal glucose concentrations during diabetic pregnancy may lead to health problems in the offspring later in life. We showed in a previous nationwide study on pregnancy outcome in type 1 diabetic women that prepregnancy care was good and a near-optimal glycaemic control during pregnancy was achieved (mean HbA1c 6.2 % ).

Aims

We investigated to what extent current care and treatment of pregnant women with type 1 diabetes were related to cardiovascular and metabolic disturbances in the offspring at school age. Additionally, we studied the influence of level of maternal glycaemic control, preterm birth and neonatal macrosomia (birth weight > p90).

Study design

Observational cohort study.

Subjects

6–8 year old offspring of women with type 1 diabetes (ODM, n = 213) and a control group of children of non-diabetic women (n = 79).

Outcome measures

BMI, blood pressure, parameters of fasting glucose regulation and lipid metabolism, components of the metabolic syndrome (overweight, hypertension, impaired fasting glucose, dyslipidaemia).

Results

Parameters of fasting glucose regulation and lipid metabolism and the frequency of components of the metabolic syndrome did not significantly differ between ODM and controls. Systolic blood pressure was slightly higher in ODM. The influence of level of maternal glycaemic control, preterm birth and neonatal macrosomia on outcome in ODM was limited.

Conclusions

Current care and treatment of pregnant women with type 1 diabetes result in cardiovascular and metabolic outcome in the offspring at 6–8 years of age that is comparable to that in children of non-diabetic women. Further follow-up should substantiate these results at later age.